We have extensive experience in all aspects of life sciences finance, including institutional sales, capital markets, investment banking, investor and public relations, sell-side analysis, and buy-side analysis. We have an equally strong foundation in the life sciences (6 Ph.D.s on staff), which enables us to understand our clients’ R&D, regulatory, and commercial strategy. The combination of financial service and life science expertise allow us to best serve our clients’ needs.

Account Managers

Managing Director, Head of Europe

Chris has over 20 years of experience in the life sciences industry covering business development, investor relations, public relations, journalism, investing, and molecular neurobiology. He is the founder of BioConfidant Sàrl a Geneva-based strategic consulting firm that helped senior executives achieve their financing and partnering goals. Previously, while at Addex Therapeutics (SIX:ADXN), Chris was a member of the executive management board and held the positions of Head of Investor Relations & Communication (2007-2010) and Director Business Development (2010-2013). He co-founded the Alpine Institute for Drug Discovery in 2013, a not-for-profit social enterprise whose mission is to help commercialize academic discoveries. In addition, Chris worked as: a journalist for the leading biotechnology trade publication BioCentury (2001-2007); an Associate at Casdin Life Science Partners (later Cooper Hill), a NYC-based biotechnology hedge-fund (1997-2000); and a molecular neurobiologist studying drug dependence at The Rockefeller University (1993-1997), where he co-authored twelve peer-reviewed publications. Chris holds a BA in English Literature from Yale University, where he also completed pre-medical studies.

Account Manager

Hans is an investor relations and corporate communications executive with over 25 years of corporate and agency experience. He has been involved in shaping the communication strategies for private financings, M&A, partnering, and IPOs, which in aggregate exceed $1.5 billion. Recently he was Head of Investor Relations & Corporate Communications of Symetis, which was acquired by Boston Scientific for EUR 425 million. He held the same position at Amsterdam Molecular Therapeutics/uniQure at the time of the company’s first IPO in 2007, and from 2000 until 2007 at IsoTis OrthoBiologics, managing the Company’s IPO, M&A transactions, and its three stock market listings in Amsterdam, Zurich, and Toronto. At the start of his career, Hans worked with Amgen International for five years, as it was establishing its footprint outside the U.S. Hans has BA degrees in Portuguese Linguistics & Literature, the Philosophy of Law, and Translation Sciences, and an MA in Italian Literature & Linguistics from the University of Amsterdam. He is fluent in Dutch, English, Italian, and French. A Dutch national, Hans is based in Switzerland, and is an avid open water swimmer.

Associate Relationship Manager

Ligia is experienced in global healthcare and financial communication. Working at Edelman and Prosek Partners, she built global brand awareness and shaped the communication strategies around M&A, corporate restructurings, FDA and EMA approvals for clients. Ligia is based in London, UK.

Directrice Media France

An experienced public relations professional in France, having previously worked at Edelman’s Paris office. Sophie runs financial communication and retail media relations in French speaking territories. Sophie is based in Paris, France.

Non-Deal Roadshows

Managing Director & Head of European Corporate Access

Niki started in institutional equity sales almost 20 years’ ago, initially in US equity sales at Cowen and JP Morgan, and then specialised in US healthcare stocks & later also European Healthcare stocks at JP Morgan and Fortis Bank, with a particular focus on Biotechnology companies at the latter. In 2009 she founded Aetia Ltd, a UK based healthcare specialist financial services firm offering capital raising and investor access services to private and public healthcare companies around the world, further developing her long-standing relationships with the healthcare investment community across Europe. During her career, Niki has managed numerous deal and non-deal roadshows across the UK and Europe and has a successful track record raising capital for a wide range of both public and private global life science companies at various stages of development. Prior to her investment banking career, Niki worked at Pricewaterhouse Coopers. She has a BSc in Business Management and Languages from Kings’ College, London.

Managing Director, Switzerland

Floriane, is managing director of Investment Connections (Geneva, Switzerland), which she founded in 2004. Her firm has developed close working relationships with a broad spectrum of European investors, including generalists, family offices, high net worth individuals and institutional investors including healthcare specialists. Previously, Floriane worked with European Investor Relations SA (now Voxia), where she was responsible for the internal management of the EIR team as well as assisting clients directly with their European roadshows. Floriane holds a Master Degree in Business Management from HEC (Hautes Etudes Commerciales) – University of Geneva.

Managing Director, France & Germany

Anne has over 20 years’ experience in institutional equity sales. She started her career at Banque Harwanne and joined the Banque NSM (ABN AMRO Group) where she became head of Institutional Sales Europe. In 2004, she founded Finapsis an independent advisory firm specialising in fundraisings for listed and non listed companies, where she completed numerous transactions in healthcare and software. Anne graduated from the Reims Management School.

Managing Director

Norma has over 20 years’ experience in institutional equity sales and has been heavily involved in marketing PIPEs, IPOs and secondary offerings to European specialist healthcare & tech funds. For the last 8 years Norma was healthcare specialist sales on the US institutional equity desk at Oppenheimer in London, covering UK, Swiss and German specialist investors. She spent the first half of her career on the US equity sales desk at CIBC in London where she had overall responsibility for Swiss investors and managed a team selling the firm’s US equity research product into Switzerland while personally focusing on healthcare and technology stocks. Norma earned a BSc in Financial Economics from University of London.